Suppr超能文献

欧洲癌症研究与治疗组织随机对照试验中保肾手术与根治性肾切除术对肾功能和总生存的探索性亚组分析。

Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy.

机构信息

Department of Urology, University of Rochester Medical Center, Rochester, New York, USA; Quantitative Safety and Epidemiology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.

Department of Urology, University of Rochester Medical Center, Rochester, New York, USA.

出版信息

Eur Urol Focus. 2017 Dec;3(6):599-605. doi: 10.1016/j.euf.2017.02.015. Epub 2017 Apr 4.

Abstract

BACKGROUND

In the European Organization for Research and Treatment of Cancer (EORTC) randomized trial 30904, nephron-sparing surgery (NSS) reduced the risk of renal dysfunction compared with radical nephrectomy (RN); however, overall survival was better in the RN arm.

OBJECTIVE

To determine whether treatment effect on the risk of renal dysfunction and all-cause mortality differed in magnitude across levels of baseline variables.

DESIGN, SETTING, AND PARTICIPANTS: This was an exploratory subgroup analysis of EORTC 30904, a phase 3 randomized trial conducted in patients with a small (≤5cm) renal mass and normal contralateral kidney.

INTERVENTION

Patients were randomized to RN (n=273) or NSS (n=268).

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

End points included follow-up estimated glomerular filtration rate (eGFR) <60ml/min/1.73m, eGFR <45ml/min/1.73m, eGFR <30ml/min/1.73m, and all-cause mortality. Treatment effect was examined within baseline variables: age (<62 vs ≥62 yr), sex, chronic disease (any vs none), performance status (0 vs≥1), and serum creatinine ≤1.25 vs >1.25×upper limit of normal (ULN). Logistic and Cox regression models were used for analysis of renal dysfunction and all-cause mortality, respectively.

RESULTS AND LIMITATIONS

The median follow-up periods were 6.7 yr for eGFR and 9.3 yr for survival. No variable-by-treatment interactions were significant at alpha=0.05. For patients with baseline creatinine >1.25×ULN (n=36), estimated mortality hazard ratio (HR) for NSS versus RN reversed its direction (HR=0.76, 95% confidence interval [CI]: 0.17-3.39) relative to the rest of the study cohort (HR=1.56, 95% CI: 1.06-2.29), although this reversal was not statistically significant (interaction p=0.25). This analysis was limited by low power.

CONCLUSIONS

This exploratory analysis did not reveal strong evidence of treatment effect modification in EORTC 30904, but it was limited by low power.

PATIENT SUMMARY

We aimed to determine whether the effect of partial versus radical nephrectomy on kidney function and overall survival depended on age, sex, and baseline health of patients enrolled in a large clinical trial. Such dependence could not be demonstrated in this analysis.

摘要

背景

在欧洲癌症研究与治疗组织(EORTC)的随机试验 30904 中,与根治性肾切除术(RN)相比,保留肾单位手术(NSS)降低了肾功能障碍的风险;然而,RN 组的总生存情况更好。

目的

确定治疗对肾功能障碍和全因死亡率风险的影响是否在基线变量水平上存在显著差异。

设计、地点和参与者:这是 EORTC 30904 的一项探索性亚组分析,该试验是一项在患有小(≤5cm)肾肿瘤且对侧肾脏正常的患者中进行的 3 期随机试验。

干预措施

患者被随机分配到 RN 组(n=273)或 NSS 组(n=268)。

结局测量和统计分析

终点包括随访时估计肾小球滤过率(eGFR)<60ml/min/1.73m、eGFR<45ml/min/1.73m、eGFR<30ml/min/1.73m 和全因死亡率。在基线变量内检查治疗效果:年龄(<62 岁与≥62 岁)、性别、慢性疾病(有或无)、表现状态(0 与≥1)和血清肌酐≤1.25 倍与正常上限(ULN)相比>1.25 倍。分别使用逻辑回归和 Cox 回归模型分析肾功能障碍和全因死亡率。

结果和局限性

eGFR 的中位随访期为 6.7 年,生存的中位随访期为 9.3 年。在 alpha=0.05 时,没有变量与治疗的交互作用具有统计学意义。对于基线肌酐>1.25×ULN(n=36)的患者,与研究队列的其余部分相比,NSS 与 RN 的估计死亡率风险比(HR)发生了逆转(HR=0.76,95%置信区间[CI]:0.17-3.39),尽管这种逆转没有统计学意义(交互作用 p=0.25)。这项分析受到低效能的限制。

结论

这项探索性分析并未显示 EORTC 30904 中治疗效果存在明显的修饰作用,但受到低效能的限制。

患者总结

我们旨在确定部分肾切除术与根治性肾切除术对参加大型临床试验的患者的肾功能和总体生存的影响是否取决于年龄、性别和基线健康状况。在这项分析中,无法证明存在这种依赖性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验